Abstract Expression of the receptor tyrosine kinase HER3 is negatively correlated with survival in ovarian cancer, and HER3 overexpression is associated with cancer progression and therapeutic resistance. Thus, improvements in HER3-targeted therapy could lead to significant clinical impact for ovarian cancer patients. Previous work from our group established multivalency as a potential strategy to improve the therapeutic efficacy of HER3-targeted ligands, including affibodies....
Alexandros G .Sfakianakis,ENT,Anapafeos 5 Agios Nikolaos Crete 72100 Greece,00302841026182
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Purpose of Review Heart failure is associated with an enormous burden on both patients and health care systems in the USA. Seve...
-
Ειδοποίηση Μελετητή:[ "κλιματική αλλαγή" ] [PDF] Ρομποτική στην αυτοκινητοβιομηχανία Γ Λιάσκος - 2017 Page 1. ΣΧΟΛΗ ΤΕΧΝΟΛΟΓΙΚΩΝ ...
-
Does CBD Oil Lower Blood Pressure? This article was originally published at SundayScaries." Madeline Taylor POSTED ON January 13, 20...
-
Πέμπτη, 22 Ιουνίου 2017 Treatment of Primary and Metastatic Multifocal Mucosal Melanoma of the Oral Cavity with Imatinib Treatment of Primar...
-
ONKO-Internetportal-Team Mammakarzinom: Molekulare Diagnostik und Erkenntnisse zum Lebensstil In einer Langzeitbeobachtung von der Geburt ...
-
Ροές που μπορεί να σας αρέσουν Να μην εμφανιστεί αυτό ξανά Cardiovascular / Cardiology News From Medical News Today Latest Health News and M...
-
Oral Candida colonization in xerostomic post‐radiotherapy head and neck cancer patients 16h ... Oral Candida colonization in xerostomic post...
-
Abstract Visible and infrared image registration is required for multi-sensor fusion and cooperative processing. However, traditional sing...
-
Journal of visualized experiments : JoVE,http://www.jove.com/ Surface Electromyographic Biofeedback... Journal of visualized experiments : J...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου